FOF/PE/VC  Spring Mountain Capital

http://springmountaincapital.com





     Office Locations:

650 Madison Avenue, 20th Floor
New York, NY 10022
Phone: 212-292-8300

 

Stages:

  • Expansion
  • Growth
  • Middle Market


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Spring Mountain Capital is a private investment management firm, founded in 2001 by John L. (Launny) Steffens, that focuses on alternative asset investing and offers investors a wide range of strategies designed to produce attractive risk-adjusted returns. SMC is organized into four investment groups: Growth Equity, Total Return, Private Capital and Municipal Bonds. For direct growth investments, Spring Mountain targets firms with $2-15mm+ of revenues and 30%+ topline growth in Technology-enabled businesses and healthcare. Typical investment size ranges from $5-15 million over the life of an investment. The firm seeks minority investments with board representation. Target sectors include: Enterprise software, Technology-enabled services, Healthcare services, and Digital health. The firm has 23 employees, including 17 investment professionals.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Greg Sandukas Managing Director, General Counsel and Chief Compliance Officer
    Gregory P. Ho President
    Jamie Weston Managing Director
    Jason L. Orchard CFA Managing Director
    John Gu Principal

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/04/2022


      Vergent Bioscience


      MN


      $21,500,000


      Series B


      02/16/2022


      Eyrus


      DC


      $12,000,000


      Series A


     

    Portfolio companies include:


      180 Health Partners
        web link


      Aware
        web link


      Doctor.com
        web link


      Eyrus
        web link


      IsoPlexis
        web link


      Maven


      Prevalent
        web link


      RepairSmith
        web link


      RiskSense
        web link


      SimpleReach
        web link


      Vergent Bioscience
        web link


      Whiptail
        web link


      WhipTail Secures
        web link


     

    Recent News: